The EUFEMED conference spotlights exploratory development of novel therapeutic approaches – lessons learned in the pandemic. Join regulators, sponsors and CROs to hear how the industry has overcome the challenge of conducting clinical research during a global pandemic.
Dr Jorg Taubel will co-chair a session on day one, which explores how technology has reduced the risks of pandemic effects on Phase I and II trial performance.
Join the conversation and register on the EUFEMED website.
You can read how Richmond Pharmacology responded to the pandemic in our article in PM Live.